NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

再生不良性貧血的全球市場:各治療類型,各疾病類型,各給藥途徑,各流通管道,各地區的,市場規模調查與預測(2020年∼2027年)

Global Aplastic Anemia Market Size study, by Treatment type, By disease type, Route of administration (Intravenous and oral), by Distribution channel and Regional Forecasts 2020-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1006308
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
再生不良性貧血的全球市場:各治療類型,各疾病類型,各給藥途徑,各流通管道,各地區的,市場規模調查與預測(2020年∼2027年) Global Aplastic Anemia Market Size study, by Treatment type, By disease type, Route of administration (Intravenous and oral), by Distribution channel and Regional Forecasts 2020-2027
出版日期: 2021年05月03日內容資訊: 英文
簡介

全球再生不良性貧血的市場規模在2020年∼2027年間的預測期間內,預計將以健全的成長率增長。

再生障礙性貧血市場需求的主要驅動力是全球血液疾病病例數量的增加。然而,治療費用是影響治療選擇的主要因素,高昂的治療成本會阻礙再生障礙性貧血治療市場的增長。

這份報告提供再生不良性貧血的世界市場調查,提供市場概要,市場成長要素及阻礙因素分析,市場機會,治療類型·疾病類型·給藥途徑·流通管道·各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 摘要整理

第2章 市場定義和範圍

第3章 市場動態

  • 市場影響分析(2018年∼2027年)

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 各治療類型

  • 市場概述
  • 效能:潛在的分析
  • 市場規模預測:2017年∼2027年(10億美元單位)
  • 子區隔分析
    • 骨髓移植·幹細胞治療
    • 輸血
    • 藥物治療

第6章 各疾病類型

  • 市場概述
  • 效能:潛在的分析
  • 市場規模預測:2017年∼2027年(10億美元單位)
  • 子區隔分析
    • 再生不良性貧血
    • 遺傳性骨髓不全症候群

第7章 各給藥途徑

  • 市場概述
  • 效能:潛在的分析
  • 市場規模預測:2017年∼2027年(10億美元單位)
  • 子區隔分析
    • 靜脈
    • 口服

第8章 各流通管道

  • 市場概述
  • 效能:潛在的分析
  • 市場規模預測:2017年∼2027年(10億美元單位)
  • 子區隔分析
    • 零售藥局
    • 醫院藥局
    • 線上藥局

第9章 各地區

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第10章 競爭資訊

  • 頂級市場策略
  • 企業簡介
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Ligand Pharmaceuticals Incorporated
    • Genzyme Corporation
    • Mylan N.V.
    • Biogen
    • Otsuka Pharmaceutical Co. Ltd.
    • Regen BioPharma Inc.
    • BioLineRx

第11章 調查流程

目錄

Global Aplastic Anemia Market is valued approximately USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2020-2027. Aplastic anemia is a condition that happens when your body stops generating sufficient new blood cells. The condition leaves you tired and more prone to uncontrolled bleeding and infections. Aplastic anemia, a rare and serious condition, may develop at any age. It can happen suddenly, or slowly and worsen over time. It can be either moderate or severe. Medications, blood transfusions or a stem cell transplant, also known as a bone marrow transplant, may be included in aplastic anemia treatment. Rising number of blood disorder cases across the world is the major factor stimulating the demand for aplastic anemia market. For instance, as per Statista, Hemophilia A and B and von Willebrand disease are the most prevalent types of bleeding disorders. There were around 210,454 individuals worldwide who were diagnosed with haemophilia in 2018 and 78,500 who were diagnosed with von Willebrand disease. Also, In 2018, it was estimated that more than 13,600 individuals were diagnosed with haemophilia A in the United States, while about 4,100 were diagnosed with haemophilia B. However, Treatment costs are a major factor influencing the choice of therapy. Bone marrow transplantation costs are over USD 300,000. Thus, high treatment costs are likely to hamper the growth of the market for aplastic anemia treatment.

The regional analysis of global Aplastic Anemia market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the high prevalence rate of blood disorder. Whereas Asia-Pacific is also anticipated to exhibit highest CAGR over the forecast period 2020-2027. Factors such as increase in awareness about aplastic anemia and blood disorders would create lucrative growth prospects for the Aplastic Anemia market across Asia-Pacific region.

Major market player included in this report are:

Bayer AG

Novartis AG

Pfizer Inc.

Ligand Pharmaceuticals Incorporated

Genzyme Corporation

Mylan N.V.

Biogen

Otsuka Pharmaceutical Co. Ltd.

Regen BioPharma Inc.

BioLineRx

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

Bone Marrow Transfusion/stem cell therapy

Blood Transfusion

Drug Therapy

By Diseases Type:

Acquired aplastic anemia

Inherited bone marrow failure syndromes

By Route of administration:

Intravenous

Oral

By Distribution channel:

Retail pharmacies

Hospital pharmacies

Online pharmacies

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Aplastic Anemia Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Aplastic anemia Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Aplastic anemia Market, by Treatment type, 2018-2027 (USD Billion)
    • 1.2.3. Aplastic anemia Market, by Diseases type, 2018-2027 (USD Billion)
    • 1.2.4. Aplastic anemia Market, by Route of administration, 2018-2027 (USD Billion)
    • 1.2.5. Aplastic anemia Market, by Distribution channel, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Aplastic anemia Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Aplastic anemia Market Dynamics

  • 3.1. Aplastic anemia Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Aplastic anemia Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Aplastic anemia Market, by Treatment type

  • 5.1. Market Snapshot
  • 5.2. Global Aplastic anemia Market by Treatment type, Performance - Potential Analysis
  • 5.3. Global Aplastic anemia Market Estimates & Forecasts by Treatment type 2017-2027 (USD Billion)
  • 5.4. Aplastic anemia Market, Sub Segment Analysis
    • 5.4.1. Bone Marrow Transfusion/Stem Cell Therapy
    • 5.4.2. Blood Transfusion
    • 5.4.3. Drug Therapy

Chapter 6. Global Aplastic anemia Market, by Disease type

  • 6.1. Market Snapshot
  • 6.2. Global Aplastic anemia Market by Disease type, Performance - Potential Analysis
  • 6.3. Global Aplastic anemia Market Estimates & Forecasts by Disease type 2017-2027 (USD Billion)
  • 6.4. Aplastic anemia Market, Sub Segment Analysis
    • 6.4.1. Acquired Aplastic Anemia
    • 6.4.2. Inherited Bone Marrow Failure Syndromes

Chapter 7. Global Aplastic anemia Market, by Route of administration

  • 7.1. Market Snapshot
  • 7.2. Global Aplastic anemia Market by Route of administration, Performance - Potential Analysis
  • 7.3. Global Aplastic anemia Market Estimates & Forecasts by Route of administration 2017-2027 (USD Billion)
  • 7.4. Aplastic anemia Market, Sub Segment Analysis
    • 7.4.1. Intravenous
    • 7.4.2. Oral

Chapter 8. Global Aplastic anemia Market, by Distribution channel

  • 8.1. Market Snapshot
  • 8.2. Global Aplastic anemia Market by Distribution channel, Performance - Potential Analysis
  • 8.3. Global Aplastic anemia Market Estimates & Forecasts by Distribution channel 2017-2027 (USD Billion)
  • 8.4. Aplastic anemia Market, Sub Segment Analysis
    • 8.4.1. Retail Pharmacies
    • 8.4.2. Hospital Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Aplastic anemia Market, Regional Analysis

  • 9.1. Aplastic anemia Market, Regional Market Snapshot
  • 9.2. North America Aplastic anemia Market
    • 9.2.1. U.S. Aplastic anemia Market
      • 9.2.1.1. Treatment type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.2. Diseases type breakdown estimates & forecasts, 2017-2027
      • 9.2.1.3. Route of administration breakdown estimates & forecasts, 2017-2027
      • 9.2.1.4. Distribution channel breakdown estimates & forecasts, 2017-2027
    • 9.2.2. Canada Aplastic anemia Market
  • 9.3. Europe Aplastic anemia Market Snapshot
    • 9.3.1. U.K. Aplastic anemia Market
    • 9.3.2. Germany Aplastic anemia Market
    • 9.3.3. France Aplastic anemia Market
    • 9.3.4. Spain Aplastic anemia Market
    • 9.3.5. Italy Aplastic anemia Market
    • 9.3.6. Rest of Europe Aplastic anemia Market
  • 9.4. Asia-Pacific Aplastic anemia Market Snapshot
    • 9.4.1. China Aplastic anemia Market
    • 9.4.2. India Aplastic anemia Market
    • 9.4.3. Japan Aplastic anemia Market
    • 9.4.4. Australia Aplastic anemia Market
    • 9.4.5. South Korea Aplastic anemia Market
    • 9.4.6. Rest of Asia Pacific Aplastic anemia Market
  • 9.5. Latin America Aplastic anemia Market Snapshot
    • 9.5.1. Brazil Aplastic anemia Market
    • 9.5.2. Mexico Aplastic anemia Market
  • 9.6. Rest of The World Aplastic anemia Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Bayer AG
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Novartis AG
    • 10.2.3. Pfizer Inc.
    • 10.2.4. Ligand Pharmaceuticals Incorporated
    • 10.2.5. Genzyme Corporation
    • 10.2.6. Mylan N.V.
    • 10.2.7. Biogen
    • 10.2.8. Otsuka Pharmaceutical Co. Ltd.
    • 10.2.9. Regen BioPharma Inc.
    • 10.2.10. BioLineRx

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Aplastic anemia market, report scope
  • TABLE 2. Global Aplastic anemia market estimates & forecasts by Region 2017-2027 (USD Billion)
  • TABLE 3. Global Aplastic anemia market estimates & forecasts by Treatment type 2017-2027 (USD Billion)
  • TABLE 4. Global Aplastic anemia market estimates & forecasts by Diseases type 2017-2027 (USD Billion)
  • TABLE 5. Global Aplastic anemia market estimates & forecasts by Route of administration 2017-2027 (USD Billion)
  • TABLE 6. Global Aplastic anemia market estimates & forecasts by Distribution channel 2017-2027 (USD Billion)
  • TABLE 7. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Aplastic anemia market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Aplastic anemia market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. U.S. Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. U.S. Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 19. U.S. Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 20. Canada Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. Canada Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 22. Canada Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 23. UK Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 24. UK Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 25. UK Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 26. Germany Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 27. Germany Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 28. Germany Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 29. RoE Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 30. RoE Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 31. RoE Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 32. China Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 33. China Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 34. China Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 35. India Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 36. India Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 37. India Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 38. Japan Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 39. Japan Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 40. Japan Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 41. RoAPAC Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 42. RoAPAC Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. RoAPAC Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. Brazil Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 45. Brazil Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. Brazil Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 47. Mexico Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 48. Mexico Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 49. Mexico Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. RoLA Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 51. RoLA Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 52. RoLA Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 53. Row Aplastic anemia market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 54. Row Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. Row Aplastic anemia market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Aplastic anemia market
  • TABLE 57. List of primary sources, used in the study of global Aplastic anemia market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Aplastic anemia market, research methodology
  • FIG 2. Global Aplastic anemia market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Aplastic anemia market, key trends 2019
  • FIG 5. Global Aplastic anemia market, growth prospects 2020-2027
  • FIG 6. Global Aplastic anemia market, porters 5 force model
  • FIG 7. Global Aplastic anemia market, pest analysis
  • FIG 8. Global Aplastic anemia market, value chain analysis
  • FIG 9. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Aplastic anemia market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Aplastic anemia market, regional snapshot 2017 & 2027
  • FIG 15. North America Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 16. Europe Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 17. Asia pacific Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 18. Latin America Aplastic anemia market 2017 & 2027 (USD Billion)
  • FIG 19. Global Aplastic anemia market, company market share analysis (2019)